Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,131 | 51,108 | 54,839 | 58,755 | 61,694 |
| TOTAL | $44,896 | $51,596 | $55,399 | $59,323 | $62,441 |
| Non-Current Assets | |||||
| PPE Net | 378 | 363 | 407 | 453 | 493 |
| Intangibles | 0 | 0 | 19,092 | 19,092 | 19,092 |
| Other Non-Current Assets | 373 | 424 | 474 | 524 | 572 |
| TOTAL | $751 | $787 | $19,973 | $20,069 | $20,157 |
| Total Assets | $45,647 | $52,383 | $75,372 | $79,392 | $82,598 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,378 | 2,571 | 1,314 | 1,297 | 961 |
| Other current liabilities | 0 | N/A | 1 | 12 | 34 |
| TOTAL | $1,619 | $2,813 | $1,558 | $1,545 | $1,228 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 119 | 177 | 234 | 291 | 344 |
| TOTAL | $119 | $177 | $234 | $298 | $358 |
| Total Liabilities | $1,738 | $2,990 | $1,792 | $1,843 | $1,586 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,143 | 8,119 | 8,119 | 8,119 | 8,119 |
| Common Shares | 8 | 98 | 98 | 8 | 98 |
| Retained earnings | -293,429 | -287,729 | -263,301 | -259,093 | -255,408 |
| TOTAL | $43,909 | $49,393 | $73,580 | $77,549 | $81,012 |
| Total Liabilities And Equity | $45,647 | $52,383 | $75,372 | $79,392 | $82,598 |